Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS) are essential structural elements of the Gram-negative bacterial outer membrane. Lipid A, the lipid component of LPS, acts as a hydrophobic anchor and is the primary moiety responsible for the endotoxic shock associated with Gram-negative sepsis by activating the TLR4 signaling pathway (Raetz & Whitfield, 2002, Annual Review of Biochemistry). The negatively charged phosphate groups on lipid A and surrounding phospholipids are crucial for membrane stability, as they bind divalent cations like magnesium and calcium to cross-link adjacent LPS molecules (Trimble et al., 2006, Cold Spring Harbor Perspectives in Medicine). This anionic surface serves as the specific target for cationic polypeptide antibiotics, such as polymyxins, which bind to the phosphate groups and displace the stabilizing cations (Poirel et al., 2017, Clinical Microbiology Reviews). This interaction leads to a detergent-like disruption of the outer membrane, increased permeability, and subsequent cell death. While highly effective against multi-drug resistant pathogens, targeting these components is associated with significant clinical challenges, including nephrotoxicity and the emergence of resistance through enzymatic modification of the phosphate groups (Falagas & Kasiakou, 2005, Critical Care).
Binding to negatively charged phosphate groups and displacement of divalent cations (Mg2+ and Ca2+), leading to outer membrane disruption and increased cell permeability.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS/Lipid A phosphates).